0001209191-22-013787.txt : 20220228
0001209191-22-013787.hdr.sgml : 20220228
20220228190802
ACCESSION NUMBER: 0001209191-22-013787
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220224
FILED AS OF DATE: 20220228
DATE AS OF CHANGE: 20220228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PERLROTH VICTOR
CENTRAL INDEX KEY: 0001754181
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38682
FILM NUMBER: 22692838
MAIL ADDRESS:
STREET 1: 1200 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kodiak Sciences Inc.
CENTRAL INDEX KEY: 0001468748
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270476525
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 PAGE MILL RD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: 650-281-0850
MAIL ADDRESS:
STREET 1: 1200 PAGE MILL RD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
FORMER COMPANY:
FORMER CONFORMED NAME: Oligasis, LLC
DATE OF NAME CHANGE: 20090721
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-24
0
0001468748
Kodiak Sciences Inc.
KOD
0001754181
PERLROTH VICTOR
1200 PAGE MILL ROAD
PALO ALTO
CA
94304
1
1
1
0
Chairman and CEO
Common Stock
2022-02-24
4
S
0
1000000
9.2017
D
2508038
D
Common Stock
2022-02-25
4
S
0
340000
8.9882
D
2168038
D
2,000,000 shares of common stock owned by the Reporting Person were pledged as collateral to secure obligations under a loan entered into in connection with a previously disclosed Stipulation for Settlement with the Reporting Person's spouse. The sales reported in this Form 4 were sold pursuant to a contractual enforcement action, pursuant to which the pledgee bank unilaterally liquidated the shares. The Reporting Person was not involved in the determination to sell such shares.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $8.95 to $9.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $8.72 to $9.40, inclusive.
/s/ David Peinsipp, Attorney-in-Fact for Victor Perlroth
2022-02-28